According to recent guidelines Histoacryl® (N-butyl-2 -Cyanoacrylate) injection is the first line of therapy for the endoscopic obliteration of gastric varices. Lipiodol is commonly used to facilitate the injection of Histoacryl® but it is expensive. In this study, we compare Lipiodol with Vitamin D3 injection as priming agents for Histoacryl injection in terms of efficacy and safety in the management of isolated fundal varices. Materials and Methods: This is a retrospective comparative study conducted at Gastroenterology Unit, Lady Reading Hospital Peshawar. Patients' information was collected from March 2012 to January 2020 from medical records. One hundred and seventy-one (171) patients, who had presented with upper gastrointestinal bleeding and had isolated fundal varices (IGV-1 according to Sarin Classification) on endoscopy, were included in the study. Patients were divided into two groups based on endoscopic treatment using Histoacryl plus Lipiodol or Histoacryl plus Vitamin D3. Data was statistically analyzed in terms of successful hemostasis, re-bleeding, variceal obliteration, mortality, and adverse events related to treatment, using SPSS version 25. Results: From March 2012 to January 2020, 171 patients met the criteria. 7 cases lost follow-up, and all the cases in both groups were treated successfully. There were no adverse events related to the procedure in either group. Twenty-six patients developed upper GI re-bleeding, which did not differ significantly between the two groups. There was also no difference between the groups in terms of treatment failure, complications, varices obliteration, and mortality. Conclusion: Vitamin D3 is as safe and effective as Lipoidol when used as a priming agent for Histoacryl injection for the obliteration of isolated fundal varices and can be used as a cheaper alternative to Lipiodol.